Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Amneal Pharmaceuticals, Inc. roi for the quarter ending 2026-06-30 was 8.27%, a 233.38% increase year-over-year.
Amneal Pharmaceuticals, Inc. roi for the quarter ending 2026-03-31 was 7.18%, a 354.73% increase year-over-year.
Amneal Pharmaceuticals, Inc. roi for the quarter ending 2025-12-31 was 5.12%, a change of 8.36% year-over-year.
Amneal Pharmaceuticals, Inc. roi for the quarter ending 2025-09-30 was 2.34%, a change of 8.70% year-over-year.
Amneal Pharmaceuticals, Inc. roi for fiscal 2025 was 2.88%, a change of 8.01% from fiscal 2024.
Amneal Pharmaceuticals, Inc. roi for fiscal 2024 was -5.13%, a change of -1.69% from fiscal 2023.
Amneal Pharmaceuticals, Inc. roi for fiscal 2023 was -3.44%, a change of 5.82% from fiscal 2022.
Amneal Pharmaceuticals, Inc. roi for fiscal 2022 was -9.27%, a 2261.68% decline from fiscal 2021.